1.
Eichenfield L, Gold LS, Silverberg N, Raoof T, Hooper D, Moore A, Zaiac M, Sullivan T, Kircik L, Lain E, Dhawan S, Jones T, Weiss J, Draelos Z, Ellman H, deVries T, Jankicevic J, Stuart I. Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris. J of Skin [Internet]. 2019Nov.9 [cited 2024Jul.3];3:S2. Available from: https://jofskin.org/index.php/skin/article/view/729